DefenCath

CorMedix Highlights Anti-Infective Strategy at JPM 2026

BERKELEY HEIGHTS, New Jersey | January 9, 2026 — CorMedix Therapeutics, a biopharmaceutical company focused on life-threatening infectious diseases,...

By cGxPwire Editor
January 12, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

DefenCath

CorMedix Highlights Anti-Infective Strategy at JPM 2026